Seeing Is Believing
AXSM is currently covered by 13 analysts with an average potential upside of $36.97 (65.12%) from yesterday's end of day stock price of $67.48. Axsome Therapeutics activity chart has currently 61 price targets and 99 ratings on display.
Analysts average stock forecasts to be materialized ratio is 48.12% with an average time for these price targets to be met of 84.29 days.
Highest price target for AXSM is $90, Lowest price target is $24, average price target is $57.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 07-Nov-2023. First documented stock forecast 07-Jun-2018.
Currently, out of the existing stock ratings of AXSM - 38 which are a Buy (76%), 12 which are a Hold (24%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
108
$40.52 (60.05%)
108
27 days ago
7/13 (53.85%)
$21.93 (44.12%)
60
Buy
100
$32.52 (48.19%)
100
2 months 9 days ago
5/10 (50%)
$20.12 (29.32%)
122
Buy
180
$110.11 (157.55%)
190
3 months 26 days ago
2/12 (16.67%)
$103.76 (151.93%)
116
Buy
90
$22.52 (33.37%)
75
3 months 26 days ago
1/2 (50%)
$11.71 (16.35%)
26
Buy
110
$42.52 (63.01%)
90
5 months 19 days ago
4/8 (50%)
$39.98 (53.68%)
71
What is AXSM (Axsome Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AXSM (Axsome Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AXSM (Axsome Therapeutics)?
Which analyst is the currently most bullish on AXSM (Axsome Therapeutics)?
Which analyst is the currently most reserved on AXSM (Axsome Therapeutics)?